欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/0364/001
药品名称Dacepton 10 mg/ml Injektions-/Infusionslösung
活性成分
    • Apomorphine hydrochloride hemihydrate 10.0 mg/ml
剂型Solution for injection
上市许可持有人EVER Neuro Pharma GmbH Oberburgau 3 A- 4866 Unterach am Attersee
参考成员国 - 产品名称Austria (AT)
Dacepton 10 mg/ml Injektions-/Infusionslösung
互认成员国 - 产品名称
    • Sweden (SE)
    • Netherlands (NL)
    • France (FR)
    • Italy (IT)
    • Greece (GR)
    • Norway (NO)
    • Estonia (EE)
    • Portugal (PT)
    • Latvia (LV)
      Dacepton 10 mg/ml šķīdums injekcijām vai infūzijām
    • Bulgaria (BG)
      Apomorph
    • Romania (RO)
      Dacepton® 10mg/ml Soluţie injectabilă/perfuzabilă
    • Slovakia (SK)
      Apomorph rds 10 mg/ml sol inj
    • Denmark (DK)
许可日期2011/03/30
最近更新日期2025/05/23
药物ATC编码
    • N04BC07 apomorphine
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase